OpenUCT Home
→
Browsing by Author

Browsing by Author "Jacques, Loretta"

Now showing items 1-5 of 5

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids

Author: Lötvall, Jan ; Bateman, Eric D ; Busse, William W ; O’Byrne, Paul M ; Woodcock, Ashley ; Toler, William T ; Jacques, Loretta ; Goldfrad, Caroline ; Bleecker, Eugene R Date: 13 Jun 2014 Background: Current maintenance therapies for asthma require twice-daily dosing. Vilanterol (VI) is a novel long-acting beta2 agonist, under development in combination with fluticasone furoate, a new inhaled corticosteroid (ICS). Findings ... Read more c b
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study

Author: Woodcock, Ashley ; Lötvall, Jan ; Busse, William W ; Bateman, Eric D ; Stone, Sally ; Ellsworth, Anna ; Jacques, Loretta Date: 09 Jul 2014 Background: Inhaled corticosteroids are a mainstay of therapy for persistent asthma, but suboptimal adherence with twice-daily use is widespread. Fluticasone furoate (FF) is a new inhaled corticosteroid (ICS) suitable for once-daily dosing ... Read more c b
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Author: Woodcock, Ashley ; Bateman, Eric D ; Busse, William W ; Lotvall, Jan ; Snowise, Neil G ; Forth, Richard ; Jacques, Loretta ; Haumann, Brett ; Bleecker, Eugene R Date: 2011 BACKGROUND: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or ... Read more c b
Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial

Author: Woodcock, Ashley ; Bateman, Eric D ; Busse, William W ; Lötvall, Jan ; Snowise, Neil G ; Forth, Richard ; Jacques, Loretta ; Haumann, Brett ; Bleecker, Eugene R Date: 01 Dec 2011 Background: Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS). This double-blind, placebocontrolled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or ... Read more c b
Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

Author: Woodcock, Ashley ; Bleecker, Eugene R ; Busse, William W ; Lotvall, Jan ; Snowise, Neil G ; Frith, Lucy ; Jacques, Loretta ; Haumann, Brett ; Bateman, Eric D Date: 2011 BACKGROUND: Inhaled corticosteroids are the recommended first-line treatment for asthma but adherence to therapy is suboptimal. The objectives of this study were to compare the efficacy and safety of once-daily (OD) evening and twice-daily ... Read more c b

Now showing items 1-5 of 5

Browse

All of OpenUCT

Browsing by Author "Jacques, Loretta"

Browsing by Author "Jacques, Loretta"

Browse

All of OpenUCT